Sectors

TXMD
TherapeuticsMD, Inc.
2.06
14 x 2.02
14 x 2.11
bid
ask
+
0.02
0.97%
09:59 AM
timesize
Ytd26.36%
1y80.68%
2.03
day range
2.06
0.99
52 week range
2.95
Open2.03Prev Close2.04Low2.03High2.06Mkt Cap23.61M
Vol1.11KAvg Vol38.31KEPS0.02P/E103.92Forward P/E3.13
Beta0.59Short Ratio0.95Inst. Own44.53%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg2.04200-d Avg1.921yr Est5.00

TXMD News

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

TherapeuticsMD Announces First Quarter 2026 Financial Results
businesswire.com
TherapeuticsMD Announces First Quarter 2026 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Full Year 2025 Financial Results
businesswire.com
TherapeuticsMD Announces Full Year 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

TherapeuticsMD Announces Third Quarter 2025 Financial Results
businesswire.com
TherapeuticsMD Announces Third Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Second Quarter 2025 Financial Results
businesswire.com
TherapeuticsMD Announces Second Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces First Quarter 2025 Financial Results
businesswire.com
TherapeuticsMD Announces First Quarter 2025 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Full Year 2024 Financial Results
businesswire.com
TherapeuticsMD Announces Full Year 2024 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
benzinga.com
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell

TherapeuticsMD Announces First Quarter 2024 Financial Results
businesswire.com
TherapeuticsMD Announces First Quarter 2024 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Full Year 2023 Financial Results
businesswire.com
TherapeuticsMD Announces Full Year 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Third Quarter 2023 Financial Results
businesswire.com
TherapeuticsMD Announces Third Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

TherapeuticsMD Announces Second Quarter 2023 Financial Results
businesswire.com
TherapeuticsMD Announces Second Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces First Quarter 2023 Financial Results
businesswire.com
TherapeuticsMD Announces First Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces First Quarter 2023 Financial Results
businesswire.com
TherapeuticsMD Announces First Quarter 2023 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
zacks.com
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy

TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
businesswire.com
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Tran

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
businesswire.com
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Tran

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ:

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
businesswire.com
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
businesswire.com
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

BOCA RATON, Fla.--( BUSINESS WIRE )--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” o

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
businesswire.com
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
businesswire.com
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

BOCA RATON, Fla.--( BUSINESS WIRE )--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” o

benzinga.com
Earnings Scheduled For August 15, 2022

  Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f

benzinga.com
99 Biggest Movers From Yesterday

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

benzinga.com
Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Friday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday